Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation
eLife · 2023
DOI: 10.7554/elife.92678 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Philip Schmassmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Brain Tumor Immunotherapy Lab, Department of Biomedicine, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Glioblastoma, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Cancer Research Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Brain Tumour Charity.
Abstract (Originalsprache)
Glioblastoma (GBM) harbors a highly immunosuppressive tumor microenvironment (TME) which influences glioma growth. Major efforts have been undertaken to describe the TME on a single-cell level. However, human data on regional differences within the TME remain scarce. Here, we performed high-depth single-cell RNA sequencing (scRNAseq) on paired biopsies from the tumor center, peripheral infiltration zone and blood of five primary GBM patients. Through analysis of >45,000 cells, we revealed a regionally distinct transcription profile of microglia (MG) and monocyte-derived macrophages (MdMs) and an impaired activation signature in the tumor-peripheral cytotoxic-cell compartment. Comparing tumor-infiltrating CD8 + T cells with circulating cells identified CX3CR1 high and CX3CR1 int CD8 + T cells with effector and memory phenotype, respectively, enriched in blood but absent in the TME. Tumor CD8 + T cells displayed a tissue-resident memory phenotype with dysfunctional features. Our analysis provides a regionally resolved mapping of transcriptional states in GBM-associated leukocytes, serving as an additional asset in the effort towards novel therapeutic strategies to combat this fatal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Brain Tumor Immunotherapy Lab, Department of Biomedicine, University of Basel, Basel, Switzerland.
- Bioinformatics Core Facility, Department of Biomedicine, University of Basel, Basel, Switzerland.
- Swiss Institute of Bioinformatics, Basel, Switzerland.
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zürich, Schlieren, Switzerland.
- Department of Neurosurgery, University Hospital Basel, Basel, Switzerland.
ORCID-Profile: Philip Schmassmann, Julien Roux, Sabrina Hogan, Tomás A Martins, Marie-Françoise Ritz
Förderung
- Swiss Cancer Research Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Brain Tumour Charity
- Department of Surgery, University Hospital Basel
Zitieren
APA
Schmassmann, P., Roux, J., Dettling, S., Hogan, S., Shekarian, T., Martins, T. A., Ritz, M. F., Herter, S., Bacac, M., & Hutter, G. (2023). Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation. eLife. https://doi.org/10.7554/elife.92678
Vancouver
Schmassmann P, Roux J, Dettling S, Hogan S, Shekarian T, Martins TA, et al. Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation. eLife. 2023. doi:10.7554/elife.92678
BibTeX
@article{Schmassmann2023,
author = {Schmassmann, Philip and Roux, Julien and Dettling, Steffen and Hogan, Sabrina and Shekarian, Tala and Martins, Tomás A and Ritz, Marie-Françoise and Herter, Sylvia and Bacac, Marina and Hutter, Gregor},
title = {Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.92678}
}
EUVIMED